Financials
| Publication of 2024 Annual Report | Jun. 26, 2025 |
| Annual Financial Report | Jun. 28, 2024 |
| Interim Results | Sep. 28, 2023 |
| Annual Financial Report | Jun. 30, 2023 |
| Interim Results | Sep. 30, 2022 |
| Annual Financial Report | Jun. 30, 2022 |
| Interim Results | Sep. 14, 2021 |
Proxies
| Notice of AGM | Nov. 18, 2024 |
| Result of AGM | Dec. 01, 2023 |
| Result of AGM | Oct. 28, 2022 |
| Notice of AGM | Oct. 06, 2022 |
| Result of AGM | Jul. 29, 2021 |
| Result of AGM | Dec. 17, 2020 |
| Notice of AGM | Nov. 27, 2020 |
Ownership Update
| Holding(s) in Company | Oct. 11, 2024 |
| Director/PDMR Shareholding | Jul. 15, 2024 |
| Holding(s) in Company | Jan. 23, 2024 |
| Holding(s) in Company | Nov. 04, 2021 |
| Director/PDMR Shareholding | Nov. 04, 2021 |
| Director/PDMR Shareholding | Dec. 31, 2018 |
Announcements
| Delisting from Euronext Growth Exchange | Jun. 05, 2025 |
| Proposed Acquisition, Disposal & Reverse Takeover | May. 07, 2025 |
| Management Changes | Mar. 03, 2025 |
| Half-year Report | Sep. 25, 2024 |
| Consultancy Agreement | Sep. 02, 2024 |
| Directorate Change | Jul. 15, 2024 |
| Summary Results of Phase II Study for Orenetide | Aug. 31, 2023 |